Immunoediting sculpts tumor epitopes during immunotherapy.

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Tumor-associated antigens undergo immunoediting under immune pressure.
• Mutations in epitopes can lead to tumor escape after immunotherapy.

Purpose of the Study:

• To investigate the impact of HER-2/neu epitope mutations on tumor outgrowth following immunotherapy.
• To evaluate the efficacy of Listeria monocytogenes-based vaccines targeting different HER-2/neu domains.

Main Methods:

• Immunization of HER-2/neu transgenic mice with Listeria monocytogenes vaccines expressing HER-2/neu fragments.
• Analysis of mutations within targeted HER-2/neu regions and their effect on T-cell responses.
• Assessment of tumor onset delay following immunotherapy.

Main Results:

• Mutations in HER-2/neu epitopes occurred in regions targeted by vaccines, correlating with vaccine efficacy.
• Vaccines targeting the kinase domain resulted in a longer delay in tumor onset.
• Mutations within novel CD8(+) T-cell epitopes abrogated CTL responses, while kinase domain mutations were limited due to signaling impairment.

Conclusions:

• The rate of escape mutant generation significantly influences vaccine efficacy.
• Targeting the HER-2/neu kinase domain may be a promising strategy due to its limited mutation potential.
• Understanding immunoediting mechanisms is crucial for developing effective cancer immunotherapies.